The value of surfactant protein a in evaluating the severity and prognosis in community-acquired pneumonia patients.

ABSTRACT:

Background

Previous research has discovered that surfactant protein A (SP-A) is involved in the pathophysiology processes of certain lung illnesses. However, no definitive clinical studies have delved into the function of SP-A in individuals afflicted with community-acquired pneumonia (CAP). A prospective cohort study was used to investigate the relationships between blood SP-A levels and the severity and prognosis among CAP patients.

Materials and methods

This study included 260 patients with CAP. Clinical traits and demographic data were examined during hospitalization. The concentrations of serum SP-A and serum interleukin-6 (IL-6) were determined by enzyme-linked immunosorbent assay (ELISA). In addition, to evaluate the severity of CAP, a variety of scores, including the

SUBMITTER: Deng YP 

PROVIDER: S-EPMC11438191 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature